A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing
19 auth.
J. Berg,
A. K. Foreman,
Julianne M. O’Daniel,
J. Booker,
Lacey J. Boshe,
T. Carey,
K. Crooks,
B. Jensen,
E. Juengst,
Kristy Lee,
...
Daniel K. Nelson,
B. Powell,
C. Powell,
M. Roche,
C. Skrzynia,
Natasha T. Strande,
K. Weck,
K. Wilhelmsen,
J. Evans
|
|
6 |
2015 |
Social Media Posts